Aehr Revenue Triples as AI Orders Pile Up: Rapid Earnings Reaction

Aehr Test Systems (AEHR -6.23%) posted record fiscal first-quarter revenue of $33.0 million, up 200% from a year ago, and shares rose about 17% in after-hours trading. The company makes burn-in systems that stress chips with heat and power to catch early failures. Orders still outran sales, and backlog now covers nearly all the revenue needed to hit the new full-year target.

Key Numbers

• Revenue: $33.0 million, up 200% year over year and 75% from the prior quarter.
• GAAP net income: $7.2 million, or $0.21 per diluted share, versus a $0.07 loss a year ago.
• Bookings: $46.7 million, a book-to-bill ratio of about 1.4.
• Fiscal 2027 revenue outlook: $150 million, up from $130 million to $150 million.

What It Means

Sales jumped while operating costs stayed nearly flat from last quarter. Most of the extra revenue fell to profit, turning last quarter’s operating loss into $6.0 million of operating income.

AEHR – Aehr Test Systems

$51.47-$3.42 (-6.23%)

NASDAQ · As of 4:00 PM ET 11/02/26

Real orders back the outlook. Aehr needs about $117 million over the next three quarters to reach its target, and nearly all of that is already on order, though the release doesn’t say how much ships this fiscal year. The new target is also just the top of the old range.

Profit hasn’t turned into cash yet. Cash fell about $11 million since the end of May, and the cash flow statement shows cash used in operations, which is common when a ramp ties up money in inventory and receivables.

What to Watch Next

Watch the test system a major AI chip supplier plans to install in Taiwan in early 2027, since a production order there could be one of Aehr’s largest deals. Also check whether operating cash flow turns positive.

David Kretzmann has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.